Sunday, September 8, 2024
HomeBusinessNextEra, Danaher, Rhythm Pharmaceuticals and more

NextEra, Danaher, Rhythm Pharmaceuticals and more

Date:

Related stories

The Role of Technology in Design-Build Construction: Transforming the Future of the Industry

Design-build construction is increasingly becoming the preferred method for...

Why It’s So Hard to Focus at Work? Top Reasons and Self-Help Tips

Does your mind constantly wander during work hours, making...

Lightweight Tablets & E-Readers for Easy Carrying in Your Bag During Monsoon

Go for these lightweight tablet & e-reader companions this...

Cristiano Ronaldo’s New Venture: The ‘UR Cristiano’ YouTube Channel

Introduction Football icon Cristiano Ronaldo has expanded his influence from...

Fabian Narvaez Discusses The Pillars of Ship Management: Technical, Crew, and Commercial

The shipping industry, pivotal to global trade, hinges on...

[ad_1]

Wind turbines at the San Gorgonio Pass wind farm, owned by NextEra Energy Inc., in Whitewater, California, on Wednesday, Feb. 17, 2021.

Bing Guan | Bloomberg | Getty Images

Check out the companies making headlines after hours.

NextEra Energy — Shares fell 3% in extended trading after the company announced its intent to sell $2 billion in equity units. Each equity unit will be issued in the amount of $50 and will consist of a contract to purchase NextEra Energy common stock in the future, as well as a 5% undivided beneficial ownership interest in a NextEra Energy Capital Holdings debenture due Sept. 1, 2027, issued in the principal amount of $1,000.

Danaher — The medical company saw shares rise 4% after announcing plans to spin off its environmental and applied solutions business to create an independent, publicly traded company. It also raised its third-quarter revenue guidance, according to FactSet.

Rhythm Pharmaceuticals — Shares of Rhythm Pharmaceuticals fell about 11% after the company announced a $100 million stock offering.

Arconic Corp — The manufacturing company’s shares slid about 8% after Arconic provided a lower-than-previously-expected revenue forecast for the full year, citing the impact of operational issues and the combination of demand declines and higher unhedged energy costs in Europe.

[ad_2]

Source link

Disclaimer: For more interesting articles visit Business Times.

See also  Across the Aisle by P Chidambaram: Whose law, whose order?
Bellie Brown
Bellie Brownhttps://businesstimes.org
Hi my lovely readers, I am Bellie brown editor and writer of Businesstimes.org. I write blogs on various niches such as business, technology, lifestyle., health, entertainment, etc as well as manage the daily reports of the website. I am very addicted to my work which makes me keen on reading and writing on the very latest and trending topics. One can check my more writings by visiting Cleartips.net

Latest stories